title: Evidence-based uncertainty: recent trial results on prostate-specific antigen testing and prostate cancer mortality.
abstract: Large-scale randomised controlled trials in Europe and the United States are informing evidence-based clinical advice.
authors.forename: David P
authors.initials: DP
authors.lastname: Smith
authors.forename: Emily
authors.initials: E
authors.lastname: Banks
authors.forename: Mark S
authors.initials: MS
authors.lastname: Clements
authors.forename: Robert A
authors.initials: RA
authors.lastname: Gardiner
authors.forename: Bruce K
authors.initials: BK
authors.lastname: Armstrong
mesh_terms: D000368:Aged; D005060:Europe / Q000453:epidemiology; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D035501:Uncertainty; D014481:United States / Q000453:epidemiology
chemical_list: D017430:Prostate-Specific Antigen